We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > NIAID

News List

NIAID and Children’s National boost paediatric clinical research alliance pharmaceutical-technology
September 20, 2018
National Institute of Allergy and Infectious Diseases (NIAID), a unit of the National Institutes of Health (NIH), has strengthened a clinical research partnership with the Children’s National Health System to tackle allergic, immunologic and infectious di
NIH begins testing Ebola treatment in early-stage trial europeanpharmaceuticalreview
May 30, 2018
Scientists developed monoclonal antibody from Ebola survivor…
Sponsored trial of a universal influenza vaccine begins europeanpharmaceuticalreview
May 10, 2018
A Phase 2 clinical trial of an investigational universal influenza vaccine intended to protect against multiple strains of the virus has begun in the United States…
Soligenix gets new funds from NIAID to develop heat-stable ricin vaccine fiercepharma
August 16, 2017
Soligenix just got another $2.5 million from a $24.7 million contract with NIAID to develop a heat-stable ricin vaccine.

Previous page 1 2 3 4 5 Next page